Kanamycin
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Short-term treatment of infections caused by E. coli, Proteus species (both indole-positive and indole-negative), Enterobacter aerogenes, Klebsiella pneumoniae, Serratia marcescens, Acinetobacter species.
- Note: other aminoglycosides including gentamicin, tobramycin, and/or amikacin are preferred in this setting.
- Staphylococcal infections (not drug of choice)
- Hepatic encephalopathy (oral formulation, no longer available in the U.S.)
- Bowel decontamination (oral formulation, no longer available in the U.S.)
NON-FDA APPROVED USES
- Treatment of multi-drug resistant Mycobacterium tuberculosis (second line)
- Non-tubercular mycobacterial (NTM) infections
- Gonorrhea
- Urinary tract infections
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Short-term treatment of infections caused by E. coli, Proteus species (both indole-positive and indole-negative), Enterobacter aerogenes, Klebsiella pneumoniae, Serratia marcescens, Acinetobacter species.
- Note: other aminoglycosides including gentamicin, tobramycin, and/or amikacin are preferred in this setting.
- Staphylococcal infections (not drug of choice)
- Hepatic encephalopathy (oral formulation, no longer available in the U.S.)
- Bowel decontamination (oral formulation, no longer available in the U.S.)
NON-FDA APPROVED USES
- Treatment of multi-drug resistant Mycobacterium tuberculosis (second line)
- Non-tubercular mycobacterial (NTM) infections
- Gonorrhea
- Urinary tract infections
There's more to see -- the rest of this topic is available only to subscribers.